Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review | Stockhead

A review of blinded data from Recce’s Phase III trial of its RECCE 327 Gel in diabetic foot infections has indicated strong efficacy.

Continue in Briflio to read, react, comment, and share.